Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder

Journal of Urology

Volumn 157, Issue 1, 1997, Pages 72-78

  Rosen, Eliot M ^b   Joseph, Ansamma ^b   Jin, Liang ^b   Yao, Yan ^b   Chau, Minh Hang T ^b   Fuchs, Alexander ^b   Gomella, Leonard ^b   Hastings, Harold ^b   Goldberg, Itzhak D ^b   Weiss, Gary H ^b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b NONE

Author keywords

bladder neoplasms; carcinoma, transitional cell; hepatocyte growth factor

Indexed keywords

SCATTER FACTOR;

ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; TRANSITIONAL CELL CARCINOMA; URINALYSIS;

EID: 0031060576     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65286-8     Document Type: Article

References (29)

1. Rosen, E. M., Nigam, S. K. and Goldberg, I. D.: Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J. Cell Biol., 127: 1783, 1994.
2. Stoker, M., Gherardi, E., Perryman, M. and Gray, J.: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature, 327: 238, 1987.
3. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K. and Shimizu, S.: Molecular cloning and expression of human hepatocyte growth factor. Nature, 342: 440, 1989.
4. Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M., Nickoloff, B. J., Kinsella, J. L., Polverini, P. and Rosen, E. M.: Scatter factor induces blood vessel formation in vivo. PNAS USA, 90: 1937, 1993.
5. Naidu, Y. M., Rosen, E. M., Zitnick, R., Goldberg, I., Park, M., Naujokas, M., Polverini, P. J. and Nickoloff, B. J.: Role of scatter factor in the pathogenesis of AIDS-related Kaposi's sarcoma. PNAS USA, 91: 5281, 1994.
6. Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F. and Aaronson, S. A.: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science, 251: 802, 1991.
7. Yoshimura, T., Yuhki, N., Wang, M. H., Skeel, A. and Leonard, E. J.: Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J. Biol. Chem., 268: 15461, 1993.
8. Wang, M.-H., Ronsin, C., Gesnel, M.-C., Coupey, L., Skeel, A., Leonard, E. J. and Breathnach, R.: Identification of the ron gene product as the receptor for human macrophage stimulating protein. Science, 266: 117, 1994.
9. Iwama, A., Okano, K., Sudo, T., Matsuda, Y. and Suda, T.: Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood, 83: 3160, 1994.
10. Joseph, A., Weiss, G. H., Jin, L., Fuchs, A., Chowdhury, S., O'Shaugnessy, P., Goldberg, I. D. and Rosen, E. M.: Expression of scatter factor in human bladder carcinoma. J. Natl. Cancer Inst., 87: 372, 1995.
11. Freund, J. E.: Mathematical Statistics, 5th ed. Englewood Cliffs, New Jersey: Prentice Hall, pp. 583-593, 1992.
12. Weidner, K. M., Behrens, J., Vandekerckhove, J. and Birchmeier, W.: Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell. Biol., 111: 2097, 1990.
13. Rosen, E. M., Knesel, J., Goldberg, I. D., Jin, L., Bhargava, M., Joseph, A., Zitnik, R., Wines, J., Kelley, M. and Rockwell, S.: Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int. J. Cancer, 57: 706, 1994.
14. Rosen, E. M., Goldberg, I. D., Liu, D., Setter, E., Donovan, M. A., Bhargava, M., Reiss, M. and Kacinski, B. M.: Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res., 51: 5315, 1991.
15. Yamashita, J., Ogawa, M., Yamashita, S., Nomura, K., Kuramoto, M., Saishoji, T. and Shin, S.: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res., 54: 1630, 1994.
16. Esrig, D., Spruck, C. H., III, Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S., Chen, S. C., Skinner, D. G., Jones, P. A. and Cote, R. J.: p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Amer. J. Path., 143: 1389, 1993.
17. Fujimoto, K., Yamada, Y., Okajima, E., Kakizoe, T., Sasaki, H., Sugimura, T. and Terada, M.: Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52: 1393, 1992.
18. Logothetis, C. J., Xu, H., Ro, J. Y., Hu, S.-X., Sahin, A., Ordonez, N. and Benedict, W. F.: Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J. Natl. Cancer Inst., 84: 1256, 1992.
19. Cairns, P., Proctor, A. J. and Knowles, M. A.: Loss of heterozygosity at the Rb locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene, 6: 2305, 1991.
20. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, C., Melamed, J., Zhang, Z.-F., Sheinfeld, J., Fair, W. R., Herr, H. W. and Reuter, V. E.: Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J. Urol., 152: 388, 1994.
21. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, C., Zhang, Z. F., Sheinfeld, J., Fair, W. R., Herr, H. W. and Reuter, V. E.: Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J. Natl. Cancer Inst., 85: 53, 1993.
22. Cordon-Cardo, C., Wartinger, D., Petrylak, D., Dalbagni, G., Fair, W. R., Fuks, Z. and Reuter, V. E.: Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J. Natl. Cancer Inst., 84: 1251, 1992.
23. Ueba, T., Nosaka, T., Takahashi, J. A., Shibata, F., Florkiewicz, R. Z., Vogelstein, B., Oda, Y., Kikuchi, H. and Hatanaka, M.: Transcriptional regulation of basic fibroblast growth factor by p53 in human glioblastoma and hepatocellular carcinoma cells. PNAS USA, 91: 9009, 1994.
24. Dameron, K. M., Volpert, O. V., Tainsky, M. A. and Bouck, N.: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 265: 1582, 1994.
25. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B. and Reed, J. C.: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994.
26. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F. and Folkman, J.: Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst., 86: 356, 1994.
27. Dickinson, A. J., Fox, S. B., Persad, R. A., Hollyer, J., Sibley, G. N. and Harris, A. L.: Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Brit. J. Urol., 74: 762, 1994.
28. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S. and Gasparini, G.: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875, 1992.
29. Toi, M., Kashitani, J. and Tominaga, T.: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int. J. Cancer, 55: 371, 1993.